Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Izzo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2009
Hypertension in athletesJohn J Leddy, Joseph Izzo
Journal of the American Society of Hypertension : JASH|February 7, 2016
Controversies in hypertension: rationale and approachJoseph Izzo, Sheldon Tobe, Daniel Levy
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2004
Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockadeMichael Weber, Jan Basile, Joseph Izzo, et al.
American Journal of Hypertension|December 4, 2002
Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applicationsAthanase Benetos, Bernard Waeber, Joseph Izzo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 2, 2010
Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?Luis Ruilope, Joseph Izzo, Hermann Haller, et al.
Journal of General Internal Medicine|May 18, 2006
Brief report: Internal medicine residents', attendings', and nurses' perceptions of the night float systemElie A Akl, Anshu Bais, Ellen Rich, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertensionHenry R Black, Myron H Weinberger, Das Purkayastha, et al.
Journal of Hypertension|October 17, 2017
Predictors for the development of microalbuminuria and interaction with renal functionChristos Chatzikyrkou, Jan Menne, Joseph Izzo, et al.
The American Journal of Emergency Medicine|November 27, 2020
Multi-center implementation of automated age-adjusted D-dimer results reduces unnecessary PE imagingJeffrey Dubin, Mary Kathleen Ratay, Matt Wilson, et al.
Therapeutic Advances in Cardiovascular Disease|July 30, 2009
EXCEED: Exforge-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristicsAmira Hassanein, Akshay Desai, Anil Verma, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2009
Hypertension in athletesJohn J Leddy, Joseph Izzo
Journal of the American Society of Hypertension : JASH|February 7, 2016
Controversies in hypertension: rationale and approachJoseph Izzo, Sheldon Tobe, Daniel Levy
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2004
Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockadeMichael Weber, Jan Basile, Joseph Izzo, et al.
American Journal of Hypertension|December 4, 2002
Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applicationsAthanase Benetos, Bernard Waeber, Joseph Izzo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 2, 2010
Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?Luis Ruilope, Joseph Izzo, Hermann Haller, et al.
Journal of General Internal Medicine|May 18, 2006
Brief report: Internal medicine residents', attendings', and nurses' perceptions of the night float systemElie A Akl, Anshu Bais, Ellen Rich, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertensionHenry R Black, Myron H Weinberger, Das Purkayastha, et al.
Journal of Hypertension|October 17, 2017
Predictors for the development of microalbuminuria and interaction with renal functionChristos Chatzikyrkou, Jan Menne, Joseph Izzo, et al.
The American Journal of Emergency Medicine|November 27, 2020
Multi-center implementation of automated age-adjusted D-dimer results reduces unnecessary PE imagingJeffrey Dubin, Mary Kathleen Ratay, Matt Wilson, et al.
Therapeutic Advances in Cardiovascular Disease|July 30, 2009
EXCEED: Exforge-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristicsAmira Hassanein, Akshay Desai, Anil Verma, et al.
Pageof 2